← Leaderboards
Joshua John Breunig
Cedars-Sinai Medical Center
$4,155,429
Attributed
$4,910,423
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $877.2K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,910,423 · 6
By mechanism
R33$3,312,935 · 3
R01$925,488 · 1
R56$584,500 · 1
R03$87,500 · 1
Top collaborators
- Jonathan G Kaye3 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGeneticMediatingIn VivoSignal TransductionGenesElectroporationMalignant NeoplasmsElementsMolecularProteinsInsightPathologicTranscriptomicsSingle-Cell Rna SequencingAdvanced DevelopmentEngineeringApplications GrantsEvolutionMutationPlasmidsGene Transfer TechniquesGenerationsCrispr/Cas Technology
Grant awards (12)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia$462,744
R01 · FY2025 · NS · contact PI
Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis$410,332
R33 · FY2025 · CA · contact PI
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia$462,744
R01 · FY2024 · NS · contact PI
Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis$414,491
R33 · FY2024 · CA · contact PI
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia$584,500
R56 · FY2023 · NS · contact PI
GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models$413,102
R33 · FY2021 · CA · contact PI
GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models$413,102
R33 · FY2020 · CA · contact PI
GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models$413,100
R33 · FY2019 · CA · contact PI
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers$418,127
R33 · FY2018 · CA · contact PI
Direct Differentiations of iPSCs: an Autologous and Scalable Source of Striatal Medium Spiny Neurons for Cellular Transplantation Therapy$87,500
R03 · FY2018 · NS · contact PI
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers$412,553
R33 · FY2017 · CA · contact PI
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers$418,128
R33 · FY2016 · CA · contact PI